NASDAQ:FDMT | Income Statement | 4D Molecular Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$3.78M$80.81M-$77.03M$4.09M$0.00-$72.94M-$1.04-$1.0470,272,01870,272,018
2026-03-31$3.05M$76.67M-$73.62M$4.86M$0.00-$68.76M-$1.01-$1.0168,064,58668,064,586
2025-12-31$85.09M$70.38M$14.72M$4.68M$0.00$19.4M$0.43$0.431,996,2901,996,290
2025-09-30$90,000.00$61.28M-$61.19M$4.31M$0.00-$56.88M-$1.01-$1.0156,126,33056,126,330
2025-06-30$15,000.00$59.47M-$59.46M$4.8M$0.00-$54.66M-$0.98-$0.9855,927,09155,927,091
2025-03-31$14,000.00$53.64M-$53.62M$5.65M$0.00-$47.97M-$0.86-$0.8655,744,04755,744,047
2024-12-31$1,000.00$56.12M-$56.12M$6.45M$0.00-$49.67M-$0.90-$0.90566,029566,029
2024-09-30$3,000.00$51.14M-$51.13M$7.29M$0.00-$43.84M-$0.79-$0.7955,554,47655,554,476
2024-06-30$5,000.00$42.46M-$42.46M$7.5M$0.00-$34.95M-$0.63-$0.6355,282,75455,282,754
2024-03-31$28,000.00$38.16M-$38.14M$5.74M$0.00-$32.4M-$0.66-$0.6649,271,98449,271,984
2023-12-31-$19,000.00$36.63M-$36.65M$4.37M$0.00-$32.28M-$0.77-$0.771,245,7041,245,704
2023-09-30$20.2M$34.18M-$13.97M$3.72M$0.00-$10.26M-$0.24-$0.2442,256,62942,256,629
2023-06-30$239,000.00$32.38M-$32.14M$2.52M$0.00-$29.62M-$0.77-$0.7738,335,21938,335,219
2023-03-31$298,000.00$30.4M-$30.11M$1.42M-$28.68M-$0.88-$0.8832,723,53032,723,530
2022-12-31$1.25M$29.97M-$28.72M$1.34M-$27.38M-$0.84-$0.8446,14746,147
2022-09-30$500,000.00$27M-$26.5M$804,000.00-$25.69M-$0.79-$0.7932,385,79132,385,791
2022-06-30$162,000.00$28.59M-$28.43M$340,000.00-$28.09M-$0.87-$0.8732,324,39232,324,392
2022-03-31$1.22M$27.61M-$26.39M$54,000.00-$26.34M-$0.82-$0.8232,232,37832,232,378
2021-12-31$92,000.00$24.86M-$24.76M-$319,000.00-$25.08M-$0.85-$0.85911,825911,825
2021-09-30$1.37M$15.84M$24.03M-$22.66M$422,000.00-$22.24M-$0.82-$0.8227,022,38027,022,380
2021-06-30$14.58M$15.22M$22.18M-$7.6M$7,000.00-$7.59M-$0.28-$0.2826,739,14926,739,149
2021-03-31$2M$12.77M$18.31M-$16.31M-$94,000.00-$16.41M26,690,167
2020-12-31-$977,000.00$19.45M-$20.42M-$125,000.00-$20.55M1,241,927
2020-09-30$7.42M$11.56M$15.24M-$7.82M-$17,000.00-$7.83M5,197,982
2020-06-30$3.51M$15.72M$18.78M-$15.15M-$4,000.00-$15.15M5,183,955
2020-03-31$3.41M$13.16M$16.81M-$13.28M$117,000.00-$13.16M5,183,845

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$85.21M$244.76M-$159.55M$19.44M$0.00-$140.11M-$2.42-$2.4257,930,18057,930,180
2024-12-31$37,000.00$187.88M-$187.84M$26.97M$0.00-$160.87M-$2.98-$2.9853,943,74153,943,741
2023-12-31$20.72M$133.59M-$112.87M$12.03M$0.00-$100.84M-$2.58-$2.5839,130,06739,130,067
2022-12-31$3.13M$113.16M-$110.03M$2.54M$0.00-$107.49M-$3.32-$3.3232,351,22132,351,221
2021-12-31$18.04M$89.37M-$71.33M$16,000.00$0.00-$71.32M-$2.57-$2.5727,730,42027,730,420
2020-12-31$13.36M$70.28M-$56.66M-$29,000.00$0.00-$56.69M6,430,555
2019-12-31$6.96M$57.75M-$50.76M$1.46M-$49.31M5,142,560